Glycogen storage disease type II other imaging findings
|
Glycogen storage disease type II Microchapters |
|
Differentiating Glycogen storage disease type II from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Glycogen storage disease type II other imaging findings On the Web |
|
American Roentgen Ray Society Images of Glycogen storage disease type II other imaging findings |
|
FDA on Glycogen storage disease type II other imaging findings |
|
CDC on Glycogen storage disease type II other imaging findings |
|
Glycogen storage disease type II other imaging findings in the news |
|
Blogs on Glycogen storage disease type II other imaging findings |
|
Directions to Hospitals Treating Glycogen storage disease type II |
|
Risk calculators and risk factors for Glycogen storage disease type II other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]
Overview
Dual energy X-ray absorptiometry (DXA) may be helpful in the diagnosis of osteoporosis, osteopenia, and/or fracture in patients with glycogen storage disease type 2. Findings on an dual energy X-ray absorptiometry suggestive of osteoporosis and/or osteopenia in patients with glycogen storage disease type 2 include low bone mineral density (BMD).
Other Imaging Findings
Dual Energy X-ray Absorptiometry
- Dual energy X-ray absorptiometry (DXA) may be helpful in the diagnosis of osteoporosis, osteopenia, and/or fracture in patients with glycogen storage disease type 2.[1]
- Dual energy X-ray absorptiometry is used to diagnose low bone mineral density (BMD).
References
- ↑ ACMG Work Group on Management of Pompe Disease. Kishnani PS, Steiner RD, Bali D, Berger K, Byrne BJ; et al. (2006). "Pompe disease diagnosis and management guideline". Genet Med. 8 (5): 267–88. doi:10.109701.gim.0000218152.87434.f3 Check
|doi=value (help). PMC 3110959. PMID 16702877.